Super Achiever Club

Qunol Mega Ubiquinol CoQ10 100 mg Review

Updated Jul 13, 2026 · Felix Hesse · Verified by SAC team

Qunol Mega Ubiquinol CoQ10 100 mg, 60 softgels — bottle in the SAC kitchen sceneSAC Studio
Best Active Form (Ubiquinol)BUY
8.9/10SAC Product Score™
How the score breaks downHide breakdown
SAC Product Score™ — how it breaks down
  • Form (ubiquinol vs ubiquinone)30%9.5
  • Absorption formulation25%9.5
  • Testing + Kaneka chain-of-custody20%8.5
  • Cost per active mg15%7.0
  • Real-world response10%9.0

The active-form pick — Kaneka ubiquinol in a water-soluble base, the most retail-available CoQ10 there is.

~$37Check on Amazon →
Buy if…
  • You're over 40 or on a statin and want the active, reduced ubiquinol form rather than ubiquinone
  • You're running a supervised fertility protocol (egg or sperm quality) and want ubiquinol for the over-35 demographic
Skip if…
  • You're under 40, healthy, and not on a statin — buy Doctor's Best (#3) ubiquinone at a third of the price
  • Cost per active mg is your top constraint — Jarrow (#1) or Healthy Origins (#6) ship comparable Kaneka ubiquinol for less
Read the full analysis
Also buy if…
  • You value buying CoQ10 off a pharmacy shelf today — Qunol is at CVS, Walgreens, Walmart, Costco
  • The water+fat-soluble formulation and the cardiologist-recommended brand trust matter to you
Also skip if…
  • You want a fully itemised carrier formulation — Qunol's proprietary base is less transparent than Jarrow's named MCT softgel

Qunol Mega Ubiquinol CoQ10 is the bottle to buy if you specifically need the active, reduced form of CoQ10 — you're over 40, on a statin, or running a fertility protocol where the conversion-efficiency math makes ubiquinol the right call over the cheaper ubiquinone that suits younger buyers. It ships Kaneka-sourced ubiquinol (the fermentation-derived raw material behind the academic literature) at a clean 100 mg per softgel, dropped into Qunol's patented water-and-fat-soluble base — the brand's genuine differentiator and the reason it carries the '#1 Cardiologist Recommended Form of CoQ10' positioning. At roughly $37 for 60 softgels it's the priciest tier of the Kaneka ubiquinol market, and the proprietary base means Qunol doesn't itemise the exact carrier the way Jarrow does.

But no ubiquinol is easier to find on a pharmacy shelf, and for the over-40-and-statin buyer the form is exactly right. Here's the full breakdown.

Read the complete CoQ10 guide →See the full ranking
Best CoQ10 Supplements
▸ THE SCORE

How we built the SAC Product Score™ — 8.9/10

Form (ubiquinol vs ubiquinone)30%9.5/10

Kaneka-sourced ubiquinol — the reduced, pre-activated form with 2-4× better bioavailability versus ubiquinone in adults over 40 and statin users (Zhang 2018, Hosoe 2007). The ubiquinol ingredient is the Kaneka fermentation-derived material that anchors the academic ubiquinol literature. Maximum form score for the exact population Qunol targets — the over-40, statin, and fertility-protocol buyer where the endogenous conversion bottleneck makes ubiquinol the correct form. (For healthy under-40 buyers, the form advantage shrinks and cheaper ubiquinone is the rational call.)

Absorption formulation25%9.5/10

Qunol's patented water-and-fat-soluble base is the brand's real differentiator. CoQ10 is a waxy, fat-soluble molecule that dissolves poorly even in fat and not at all in water — Qunol's formulation solubilises it in both, which is the genuine mechanism behind 'superior absorption' and reduces the take-with-fat dependency that plagues bare powder-in-capsule ubiquinone. Loses nothing against dry ubiquinone; near-perfect because other well-formulated ubiquinol softgels (Jarrow's MCT carrier) already pre-dissolve in oil and capture most of the same benefit — Qunol's edge is real but its magnitude over good softgels is modest.

Testing + Kaneka chain-of-custody20%8.5/10

Ubiquinol sourced from Kaneka — the gold-standard fermentation-derived raw material — manufactured under Qunol's quality program with the brand's mass-market regulatory exposure (a brand this visible at this retail scale carries real label-accuracy accountability). Loses 1.5 points from a perfect 10 because Qunol does not publish per-batch COAs with public lot lookup, and the patented proprietary base means the exact carrier composition isn't itemised the way Jarrow names its MCT softgel. The Kaneka sourcing is the trust anchor; the public-facing transparency sits a tier below the Thorne / NSF Sport standard.

Cost per active mg15%7/10

~$37/60 softgels = ~$0.62 per 100 mg softgel = ~$0.0062 per active mg. The top of the ubiquinol price band — roughly 30% more per active mg than Jarrow QH-Absorb (#1) and meaningfully more than Healthy Origins (#6), all shipping comparable Kaneka-grade ubiquinol. The premium pays for the patented solubility formulation, the heavy brand marketing, and the unmatched pharmacy distribution — not for a better ubiquinol molecule. This is the criterion that keeps the score under 9: you can get the same active form for less.

Real-world response10%9/10

Form + formulation are calibrated to the populations where the evidence concentrates: statin users (Banach 2015 meta showed significant myalgia reduction at 100-200 mg/day), adults over 40 facing age-related CoQ10 decline (Hernández-Camacho 2018), and — as a supervised adjunct — fertility patients where mitochondrial ATP underpins egg and sperm quality. The water-soluble base lowers the with-a-fat-meal adherence burden, and pharmacy availability means easy re-orders — both real-world adherence factors. Slight discount from a perfect 10 because under-40 healthy buyers will see smaller felt effects regardless of brand or form.

▸ SPECS

The product at a glance

Active form
Ubiquinol (reduced form of CoQ10), sourced from Kaneka
Per softgel
100 mg ubiquinol
Bottle size
60 softgels — 2-month supply at 1/day (also sold in 100 / 120 / 240 ct)
Daily dose
1 softgel over-40 maintenance · 2 softgels statin support · 2-6 softgels supervised fertility protocol
Formulation
Patented water-and-fat-soluble base (100% water + fat soluble — the brand's differentiator)
Key positioning
#1 Cardiologist Recommended Form of CoQ10 (per IQVIA ProVoice survey)
Target buyer
Over-40, statin users, fertility protocols — the exception-to-ubiquinone demographic
Certifications
USP-verified line varies by SKU; gluten-free; manufactured under cGMP
Manufacturer
Qunol (Quten Research Institute) — mass-market, widest US pharmacy distribution
Lab transparency
Kaneka-sourced ubiquinol; proprietary base not itemised; no public per-batch COA lookup
Price
~$37 / 60 softgels (~$0.62 per 100 mg softgel) — top of the ubiquinol price band
▸ TRUTH CHECK

Marketing claims vs. reality

Verified

“Ubiquinol is the active form of CoQ10, and the body's ability to convert CoQ10 to ubiquinol diminishes with age.”

Accurate and well-established. Ubiquinol (reduced) is the form that does the electron-shuttle work in mitochondria; ubiquinone (oxidised) requires endogenous conversion. Conversion efficiency declines with age and is impaired by statins, which is why ubiquinol shows 2-4× higher plasma CoQ10 than ubiquinone in adults over 40 (Zhang 2018, PMID 30302465; Hosoe 2007). This is the single most important and most honest claim Qunol makes — and the entire rationale for choosing this bottle over cheaper ubiquinone.

Verified

“Patented formulation is 100% water and fat soluble for superior absorption versus regular CoQ10.”

Real and the brand's genuine differentiator. CoQ10 is a waxy molecule that dissolves poorly in fat and not in water; Qunol's solubility-engineered base disperses it in both, which improves absorption over bare powder-in-capsule CoQ10 and reduces the with-fat dependency. The 'superior absorption' framing is fair against unformulated CoQ10. The implicit framing that it's dramatically better than all other ubiquinol is overstated — well-formulated ubiquinol softgels (e.g. Jarrow's MCT carrier) already pre-dissolve the ubiquinol and capture most of the same gain.

Partial

“#1 Cardiologist Recommended Form of CoQ10.”

An accurate report of a real IQVIA ProVoice survey result — not fabricated. But it measures brand recommendation share and familiarity among surveyed cardiologists (driven heavily by Qunol's retail and marketing dominance), not clinical superiority of the formulation on a hard endpoint versus other ubiquinols. A legitimate trust and availability signal; not proof the molecule inside outperforms the identical Kaneka ubiquinol in a cheaper bottle.

Verified

“Beneficial for statin users — statins lower CoQ10 levels, and supplementation helps replenish them.”

Mechanistically and clinically sound. Statins inhibit HMG-CoA reductase, the shared first step of both cholesterol and CoQ10 synthesis, depleting endogenous CoQ10 over months of use. The Banach 2015 meta-analysis (PMID 25440725, 12 RCTs) found CoQ10 supplementation significantly reduced statin-induced muscle pain, weakness, cramps, and tiredness versus placebo. The statin-support positioning is one of the best-supported claims on the label.

Partial

“Helps maintain healthy blood pressure levels already within a normal range.”

Supported in direction but carefully hedged (the 'within a normal range' structure-function qualifier is the regulatory tell). The Rosenfeldt 2007 meta-analysis (PMID 17287847) found CoQ10 can modestly lower systolic and diastolic blood pressure. Real effect, but the magnitude is modest and the claim is deliberately soft — CoQ10 is a supportive adjunct, not an antihypertensive, and anyone on BP medication should monitor for additive effects.

▸ THE DEEP DIVE

What our test actually found

01The form is the whole point — and it's the right form for exactly who Qunol targets

Strip away the branding and what justifies this bottle is the ubiquinol form. CoQ10 supplements come in two flavours: ubiquinone (oxidised, cheap, dominant on the shelf) and ubiquinol (reduced, pre-activated, premium). Your body interconverts them, but the conversion enzyme slows with age and is suppressed by statins — so for the over-40, statin-using, and chronic-condition populations, ubiquinol delivers 2-4× the plasma CoQ10 of ubiquinone at the same dose (Zhang 2018, Hosoe 2007). Qunol's entire marketing — and our recommendation — is aimed squarely at that demographic. The corollary matters just as much: if you're a healthy under-40 buyer, your conversion machinery is fine, ubiquinone reaches the same endpoint, and paying the ubiquinol premium is largely wasted. Qunol is a niche winner, not a universal default — the niche being people for whom the active form genuinely earns its keep.

02The water-soluble base is a real advantage — but mostly over cheap dry ubiquinone, not over good softgels

Qunol's patented water-and-fat-soluble formulation is its honest differentiator. CoQ10 is a waxy molecule that doesn't dissolve in water and barely in fat, which is why unformulated CoQ10 powder in a capsule absorbs erratically and demands a fatty meal. Qunol solubilises the ubiquinol so it disperses in both phases, smoothing absorption and softening the take-it-with-fat rule. Against a bare ubiquinone capsule, this is a meaningful edge. Against other well-formulated ubiquinol softgels — Jarrow's MCT carrier oil, Healthy Origins' oil-suspended Kaneka — the gap narrows sharply, because those already pre-dissolve the ubiquinol in lipid. So the solubility story is genuine but context-dependent: a strong reason to pick Qunol over generic dry CoQ10, a marginal one over a good Kaneka softgel competitor.

03The fertility angle is legitimate but must stay in its lane — supervised adjunct, not a cure

The reason CoQ10 keeps appearing in fertility conversations is sound cell biology: eggs and sperm are extraordinarily energy-hungry and depend on mitochondrial ATP, which CoQ10 is essential for, and gamete quality declines with age in parallel with CoQ10. Small randomised trials and reviews have studied CoQ10 (commonly 200-600 mg/day) as an adjunct in women with diminished ovarian reserve undergoing IVF and in men for sperm count and motility, with encouraging but not definitive results. Ubiquinol is the logical form for the over-35 fertility demographic — same conversion-efficiency argument. But this belongs in a supervised protocol: CoQ10 supports the machinery, it does not treat the underlying cause of infertility, and anyone pursuing this should be doing so with a reproductive endocrinologist, not self-prescribing off a marketing claim. We rate the mechanism plausible and the evidence promising-but-immature — worth discussing with a doctor, not a guaranteed fix.

04You are paying the top of the ubiquinol price band — and the molecule isn't better for it

At ~$37 for 60 softgels (~$0.62 each), Qunol is the most expensive way to buy Kaneka-grade ubiquinol on a per-active-mg basis — roughly 30% above Jarrow QH-Absorb (#1) and well above Healthy Origins (#6), both of which ship comparable Kaneka ubiquinol. The premium buys the patented solubility tech (a modest edge over good softgels), the enormous brand-marketing machine behind the '#1 cardiologist recommended' line, and — the genuinely unique value — pharmacy distribution: Qunol is the ubiquinol you can actually grab at CVS, Walgreens, Walmart, or Costco without waiting on a shipment. If cost per active mg is your single deciding variable, buy Jarrow or Healthy Origins. If retail availability and the solubility story are worth a few dollars a month to you, the premium is defensible — just know you're paying for convenience and brand, not a superior molecule.

05The '#1 Cardiologist Recommended' badge is real survey data — read it as trust, not as proof

The badge is footnoted to the IQVIA ProVoice survey, a recurring market-research instrument that asks clinicians which brands they recommend. It's an accurate report of a real result, not a fabricated claim. What it actually measures is brand recommendation share among surveyed cardiologists — a figure powered largely by Qunol's retail ubiquity and ad spend — not a head-to-head clinical trial showing Qunol's formulation beats other ubiquinols on a hard outcome. It tells you cardiologists know and recommend the Qunol brand frequently, which is a legitimate trust and familiarity signal (and helpful if a clinician has name-checked it). It does not tell you the ubiquinol inside is clinically superior to the identical Kaneka ubiquinol in a cheaper bottle. Useful context; not evidence of molecular superiority.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Kaneka-sourced ubiquinol — the active, reduced form that's genuinely right for over-40 and statin buyers
  • Patented water-and-fat-soluble base — a real absorption edge over bare powder-in-capsule CoQ10
  • The most retail-available ubiquinol there is — stocked at CVS, Walgreens, Walmart, Costco
  • '#1 Cardiologist Recommended' (IQVIA ProVoice) brand trust + clean 100 mg/softgel that scales across protocols
  • Strongest, most honest claim on the label — ubiquinol's age/statin conversion-efficiency case is solid
Cons
  • Priciest tier of the Kaneka ubiquinol market — ~30% more per active mg than Jarrow (#1) for a comparable molecule
  • If you're 40-and-under and not on a statin, you likely don't need ubiquinol at all — cheaper ubiquinone reaches the same endpoint
  • Proprietary water-soluble base isn't itemised — less carrier transparency than Jarrow's named MCT softgel, no public per-batch COA
▸ THE BOTTOM LINE

The active-form niche winner — buy it for the ubiquinol and the availability, not for the price.

Qunol Mega Ubiquinol CoQ10 is what we recommend to the specific buyer who genuinely needs the active form: you're over 40, you're on a statin, or you're running a supervised fertility protocol where the over-35 conversion-efficiency math makes ubiquinol the right call over the cheaper ubiquinone that suits younger people. The form is the strongest, most honest part of the package — Kaneka-sourced ubiquinol delivers 2-4× the plasma CoQ10 of ubiquinone in exactly that population (Zhang 2018, Hosoe 2007), and Qunol drops it into its patented water-and-fat-soluble base, a real absorption advantage over bare powder-in-capsule CoQ10. Add the '#1 Cardiologist Recommended' trust signal and unmatched pharmacy distribution, and for the over-40-and-statin demographic this is an easy, low-friction buy. Two honest caveats keep it a niche winner rather than a universal pick. First, the price: at ~$0.62 per softgel it's the top of the ubiquinol band, and the identical-grade Kaneka ubiquinol sits in Jarrow QH-Absorb (#1) and Healthy Origins (#6) for noticeably less — you're paying for solubility tech, brand marketing, and retail convenience, not a better molecule. Second, the form only matters for the right person: if you're a healthy under-40 buyer not on a statin, your body converts ubiquinone perfectly well, and Doctor's Best ubiquinone (#3) reaches the same bioactive endpoint at roughly a third of the cost — the ubiquinol premium is money you don't need to spend. So: buy Qunol if you want the active form with the convenience of grabbing it off any pharmacy shelf and the solubility story appeals; buy Jarrow or Healthy Origins if you want the same Kaneka ubiquinol for less and don't mind ordering online; and buy ubiquinone if you're young, healthy, and statin-free. On fertility specifically — a real and growing reason people seek out ubiquinol — the mechanism is sound and the early evidence is encouraging, but treat CoQ10 as a doctor-supervised adjunct, never a standalone treatment. Within its lane, Qunol earns the 8.9.

Check price on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

▸ ALTERNATIVES

If this doesn’t fit — try these

Jarrow Formulas Ubiquinol QH-Absorb

9.2/10

The Editor's Choice ubiquinol at a lower price per active mg — licensed Kaneka QH in an MCT carrier softgel with itemised formulation. The smarter buy if you want the same active form for less and don't need pharmacy-shelf availability.

See it on the list →

Doctor's Best High Absorption CoQ10

8.7/10

The budget pick at roughly a third of Qunol's cost — generic ubiquinone with BioPerine for healthy under-40 buyers whose conversion enzyme is intact. The right call if you're not over 40, not on a statin, and don't actually need the active form.

See it on the list →

Healthy Origins Ubiquinol (Kaneka QH)

8.5/10

The Kaneka ubiquinol value pick — same reduced-form molecule as Qunol, oil-suspended softgel, the cheapest per active mg in the ubiquinol tier. The call when cost per active mg is the constraint and brand-name isn't load-bearing.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. Hosoe 2007 (Kaneka ubiquinol pharmacokinetics)Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M · 2007 · Regulatory Toxicology and Pharmacology · PMID 16919858

    Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers

    Pharmacokinetic study of Kaneka ubiquinol in healthy adults — established the dose-response curve, the safety profile up to 300 mg/day for 4 weeks, and the bioavailability advantage of the reduced form. The reference safety + PK paper for the exact Kaneka-grade ubiquinol Qunol ships.

  2. Zhang 2018 (ubiquinol vs ubiquinone)Zhang Y, Liu J, Chen XQ, Oliver Chen CY · 2018 · Food & Function · PMID 30302465

    Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men

    Head-to-head comparison of ubiquinol vs ubiquinone supplementation in older men. Ubiquinol produced significantly higher plasma CoQ10 at equivalent oral doses — the 2-4× bioavailability advantage of the reduced form in adults over 40 that is the entire reason to choose Qunol's ubiquinol over cheaper ubiquinone.

  3. Banach 2015 (statin myopathy meta)Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Lip GY, Dragan S, Mikhailidis DP · 2015 · Mayo Clinic Proceedings · PMID 25440725

    Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials

    Meta-analysis of 12 RCTs (n=575) on CoQ10 in statin users with myopathy. Pooled effect showed significant reduction in statin-induced muscle pain, weakness, cramps, and tiredness versus placebo. The evidence behind Qunol's statin-support positioning and the 200 mg/day (2-softgel) statin protocol.

  4. Rosenfeldt 2007 (blood pressure meta)Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF · 2007 · Journal of Human Hypertension · PMID 17287847

    Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials

    Meta-analysis of 12 clinical trials found CoQ10 supplementation produced modest reductions in systolic and diastolic blood pressure. Supports Qunol's hedged 'healthy blood pressure within a normal range' claim — a real but modest effect, supportive rather than a substitute for antihypertensive therapy.

  5. Xu 2018 (CoQ10 and ovarian response)Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, Wang S · 2018 · Reproductive Biology and Endocrinology · PMID 29587861

    Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial

    RCT in young women with diminished ovarian reserve undergoing IVF — CoQ10 pretreatment improved ovarian response and embryo quality versus control. Representative of the encouraging-but-not-definitive fertility evidence: a basis for discussing CoQ10 as a supervised adjunct with a fertility specialist, not for self-prescribing as a treatment.

  6. Hernández-Camacho 2018 (aging review)Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P · 2018 · Frontiers in Physiology · PMID 29459830

    Coenzyme Q10 supplementation in aging and disease

    Comprehensive review of CoQ10 in aging, cardiovascular disease, neurodegeneration, and statin complications. Establishes the age-related decline curve (~50% drop in heart and skeletal muscle by age 60) and the rationale for ubiquinol supplementation in adults over 40 — the demographic Qunol's active-form positioning targets.